Awarded in support of neuroscientist James E. Galvin and his team, the gift will be used to expand the scope and reach of the Dementia Prevention Initiative, a longitudinal study of brain aging and dementia aimed at better understanding risk factors for dementia, which include age, vascular and metabolic conditions, and inflammation. To date, the program has supported research on novel biomarkers and peripheral predictors of dementia such as physical performance, retinal imaging, and gait analysis. The new grant will enable FAU to continue the research as well as follow patients for an additional three years, share data with other investigators, provide training, and distribute information to the public.
According to FAU, up to 30 percent of those who develop Alzheimer's or a related disorder — a population that, if current trends persist, is expected to number some sixteen million in the U.S. and sixty million globally by 2050 — may be able to prevent the onset of the disease through risk factor modifications and behavioral changes. The initiative was established in 2017 with a $1 million grant from the Manguarian Foundation.
"This gift reflects our longstanding confidence in the university's and the Charles E. Schmidt College of Medicine's efforts in dementia prevention research and the resulting personalized treatment plans that Dr. Galvin and his team have developed," said Mangurian Foundation president Stephen G. Mehallis. "Moreover, the gift also will enable sharing the information generated from the Dementia Prevention Initiative with investigators from other institutions through hosting events and attracting world-renowned scientists."